Back to CVE records
Critical 9.3Published Aug 15, 2026

CVE-2026-72278KVM: arm64: nv: Re-translate VNCR before injecting abort

Updated under an hour ago ()

Does this affect you?

It affects Linux. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

In the Linux kernel, the following vulnerability has been resolved: KVM: arm64: nv: Re-translate VNCR before injecting abort KVM faults in the VNCR page with FOLL_WRITE whenever the guest aborts for a write, similar to how a regular stage-2 mapping is handled. It is entirely possible that the guest reads from the VNCR before writing to it, in which case the PFN could only be read-only. Invalidate the VNCR TLB and re-fetch the translation upon taking a VNCR abort, allowing the host mapping to be faulted in for write the second time around. Interestingly enough, this also satisfies the ordering requirements of FEAT_ETS2/3 between descriptor updates and MMU faults.

CVSS
9.3 CRITICAL (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Weakness (CWE)
Not given
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Linux
NVD analysis
Received
Record last updated
Aug 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Linux Linux
linux:linux (from the name)
from 2a359e072596fcb2e9e85017a865e3618a2fe5b5 before ea7a76d7d614b5f82b4d0785f9af3550e860a71a; 2a359e072596fcb2e9e85017a865e3618a2fe5b5 builds before 0a5dd8cf4d58ea28da132c2097cd1c525302ac48; from 2a359e072596fcb2e9e85017a865e3618a2fe5b5 before bb645aa0a4caeaf7f9cd32e9a948594d434c1a8f
CNA record

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.